These results suggest that CTRP3 maintained the barrier function of iBRB in DR by preventing the diabetes-induced Occludin and Claudin-5/tight junctions protein disruption, via AMPK-dependent signaling. Here, PRKAA1 is linked to diabetes mellitus.